These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Updated S2k Clinical Practice Guideline on Non-alcoholic Fatty Liver Disease (NAFLD) issued by the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) - April 2022 - AWMF Registration No.: 021-025. ; Z Gastroenterol; 2022 Sep; 60(9):e733-e801. PubMed ID: 36100201 [No Abstract] [Full Text] [Related]
25. [Nonalcoholic fatty liver disease: What do we know and what will we have to learn?]. Volkova NI; Porksheyan MI Ter Arkh; 2017; 89(2):91-98. PubMed ID: 28393828 [TBL] [Abstract][Full Text] [Related]
27. Prognostic value of high sensitivity C-reaction protein in non-insulin dependent diabetes mellitus patients with non-alcoholic fatty liver disease. Bi Y; Min M; Shen W; Deng P; Du Q; Dong M; Liu Y Int J Clin Exp Pathol; 2015; 8(7):8494-9. PubMed ID: 26339423 [TBL] [Abstract][Full Text] [Related]
28. Toward More Accurate Nomenclature for Fatty Liver Diseases. Eslam M; Sanyal AJ; George J Gastroenterology; 2019 Sep; 157(3):590-593. PubMed ID: 31158374 [No Abstract] [Full Text] [Related]
30. [Progress in the study of nonalcoholic fatty liver disease: insights from research in 2013]. Shen F; Fan J Zhonghua Gan Zang Bing Za Zhi; 2014 Mar; 22(3):178-80. PubMed ID: 24919224 [No Abstract] [Full Text] [Related]
31. Clinical features of pediatric nonalcoholic fatty liver disease: a need for increased awareness and a consensus for screening. Middleton JP; Wiener RC; Barnes BH; Gurka MJ; DeBoer MD Clin Pediatr (Phila); 2014 Dec; 53(14):1318-25. PubMed ID: 24477713 [No Abstract] [Full Text] [Related]
32. Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice? Edenvik P; Davidsdottir L; Oksanen A; Isaksson B; Hultcrantz R; Stål P Liver Int; 2015 Jul; 35(7):1862-71. PubMed ID: 25524812 [TBL] [Abstract][Full Text] [Related]